報價延遲最少15分鐘:2025/10/23 16:30 EDT
盤後時段
|
||||
|
253.51 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
253.51
|
|
|
| 價值評估 |
|
盈利(現時/預測)
3.78/4.88
|
|
企業價值
10.04B
|
| 資產負債 |
|
每股賬面淨值
33.18
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
1.19B
|
|
每股收益
25.51
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/10/23 16:30 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases. |
